Introduction
The adoption of a comprehensive strategy for the care of rheumatic heart disease (RHD) is of utmost importance due to its potential impact on pregnancy outcomes. This is an examination of a case study about a 30-year-old pregnant woman who has previously been diagnosed with RHD. This paper considers alternative therapies, comparisons to guidelines, opportunities for growth, and methods for future administration to enhance RHD management.
Summary of the Case
The patient’s medical history reveals a prior occurrence of a severe rheumatic fever, resulting in significant damage to their heart valves. The disease resulted in the development of mitral valve stenosis and regurgitation, which were particularly noteworthy. According to Kumar et al. (2020), the person in question was diagnosed with RHD during the second trimester of her pregnancy, which added complexity to her healthcare experience. As a result, she required a unique course of action to address both her cardiovascular condition and the difficulties that arose during her pregnancy.
The care of RHD that occurred during pregnancy necessitated the use of a multidisciplinary strategy. This group consisted of several medical professionals, including cardiologists, obstetricians, and maternal-fetal medicine specialists. The team’s comprehensive care plan was implemented through close cooperation, taking into account concerns regarding future heart surgeries, obstetric care, and medical treatment.
Management of the Patient
The use of medication has been of utmost importance in the effective treatment of symptoms related to RHD and in the prevention of potential problems that may occur during pregnancy. The patient was provided with a mix of drugs in order to effectively control fluid retention (Ralph et al., 2020). According to Parsonage et al. (2021), anticoagulants were used to reduce the risk of thromboembolic events, beta-blockers were used to regulate heart rate and blood pressure, diuretics were used to manage fluid retention, and antibiotics were used to prevent infective endocarditis. The drug selection process was guided by evidence-based guidelines from prominent scientific organizations, such as the European Society of Cardiology (ESC) and the American Heart Association (AHA).
In contrast, obstetric management emphasizes comprehensive prenatal care, with the primary goal of ensuring the health of both patients. The approach used was all-encompassing, including regular prenatal screenings, fetal ultrasound surveillance, and dietary guidelines. According to Ralph et al. (2020), the main aim of this approach was to guarantee the highest level of well-being for both the pregnant woman and the growing baby. The expecting person received a program that guided them in maintaining a healthy lifestyle throughout pregnancy (Baghel et al., 2020). The program included guidance on modifying eating choices, adapting physical activity, and consistently adhering to prescribed medicines.
Comparing the RHD Management
The patient’s care for RHD generally adheres to standards endorsed by reputable organizations such as the Royal Australian and New Zealand College of Obstetricians and Gynecologists (RANZCOG). One fundamental similarity is the use of a multidisciplinary team approach involving cardiologists, obstetricians, and maternal-fetal medicine specialists. This aligns with the 2020 Australian Guidelines’ recommendation that patients with severe rheumatic valvular disease receive specialist prenatal care at an appropriate referral facility (Ralph et al., 2020). The birth plan, as well as the coordinated efforts between the cardiology and obstetrics departments, are further examples of adherence to these evidence-based procedures.
The use of certain drugs, such as beta-blockers, diuretics, and antibiotics for endocarditis prophylaxis, as recommended, is another area of agreement. However, according to RANZCOG-endorsed recommendations, percutaneous balloon mitral valvuloplasty (PBMV) is explicitly advised for symptomatic moderate-to-severe mitral stenosis. In contrast, PBMV was not carried out in this instance (Ralph et al., 2020).
Regular monitoring of heart function was an essential component of the care delivery system. The heart’s health was regularly evaluated by diagnostic tests such as electrocardiograms, echocardiograms, and other methods to check valve function, cardiac output, and rhythm problems (Baghel et al., 2020). The installation of such monitoring would facilitate the identification of necessary adjustments to the treatment plan.
Development Discussion
Done Well
The patient was provided with a comprehensive birth plan developed in a joint effort by the cardiology and obstetrics departments. Several criteria were taken into account to mitigate the risk of difficulties and enhance the likelihood of favorable outcomes. The plan took into account several variables, including the patient’s gestational age, cardiac status, and potential risks of labor and delivery (Kumar et al., 2020).
The management approach was determined to align with evidence-based recommendations by comparing it with established guidelines from reputable organizations such as the American College of Cardiology (ACC), the European Society of Cardiology (ESC), and the RANZCOG (Baghel et al., 2020). The potential surgical interventions included valve repair and replacement, as documented by Parsonage et al. (2021). As a result, the patient’s stable cardiac state and the effectiveness of the pharmacological treatment rendered surgical intervention unnecessary for the duration of the patient’s pregnancy.
Areas for Improvement
While the therapeutic method has shown effectiveness in managing RHD throughout pregnancy, there are still numerous areas that might be improved, along with ongoing challenges. Despite the effectiveness of the treatment approach, this situation persists. One potential strategy to enhance early detection procedures is increasing awareness of the importance of regular cardiac screening, particularly for individuals with a history of rheumatic fever.
Not only is it of the utmost importance to give patients with RHD during pregnancy support, but it is also necessary to highlight the relevance of medication adherence, lifestyle modifications, and self-care practices. Patients who participate in their own healthcare may see improved treatment outcomes (Kumar et al., 2020). Future research and efforts should prioritize advancing knowledge of RHD in pregnancy, exploring novel treatment modalities, optimizing risk-stratification systems, and addressing healthcare inequities that may affect vulnerable groups’ access to care and outcomes. The management of RHD in pregnant women is a challenging endeavor that calls for a patient-centered, collaborative, and evidence-based strategy.
Conclusion and Recommendations
To conclude, the case study demonstrates treating RHD holistically to improve the prognosis for both the mother and the fetus. The management of RHD during pregnancy adhered closely to evidence-based guidelines, with the interdisciplinary strategy being a specific example of best practices recommended by RANZCOG. Improvements could have been made by including PBMV in the patient’s care plan; additionally, fostering stronger multidisciplinary collaboration and patient education could further optimize the management approach and treatment outcomes. Other recommendations include boosting cross-disciplinary cooperation, prioritizing patient education, and encouraging innovation.
References
Baghel, J., Keepanasseril, A., Pillai, A. A., Mondal, N., Jeganathan, Y., & Kundra, P. (2020). Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease. Heart, 106(18), 1400–1406.
Kumar, R. K., Antunes, M. J., Beaton, A., Mirabel, M., Nkomo, V. T., Okello, E., Regmi, P. R., Reményi, B., Sliwa-Hähnle, K., Zühlke, L. J., & Sable, C. (2020). Contemporary diagnosis and management of rheumatic heart disease: Implications for closing the gap: A scientific statement from the American Heart Association. Circulation, 142(20).
Parsonage, W. A., Zentner, D., Lust, K., Costa, S., & Sullivan, E. A. (2021). Heart disease and pregnancy: The need for a twenty-first century approach to care…. Heart Lung and Circulation, 30(1), 45–51.
Ralph, A. P., Noonan, S., Wade, V., & Currie, B. J. (2020). The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. The Medical Journal of Australia, 214(5).